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I NTRAARTERIAL pressure monitoring is routine for patients having cardiac surgery; however, the ideal site for 
arterial cannulation that best reflects central aortic pressure 
while minimizing line-associated complications is unclear. 
Radial arterial cannulation often is preferred because collat-
eral circulation from the ulnar artery to the hand reduces the 
risk of ischemic injury.1 However, radial arterial pressure often 
exaggerates central aortic pressures because of decreased arterial 
elasticity, amplification of harmonic resonance, and the water 
hammer effect, which describes a bounding and forceful pulse 
caused by the propagation of a pressure wave throughout the 
vasculature.2 Furthermore, hemodilution or radial artery vaso-
spasm during critical periods of cardiac surgery can cause radial 
arterial pressure to underestimate central aortic pressure.3,4 
Inaccurate pressure measurements even for brief periods of 
time may promote inappropriate hemodynamic management 
and possibly increase postoperative morbidity and mortality.5
Brachial arterial monitoring, in contrast, closely reflects 
central aortic pressure even during complex cardiac surgi-
cal procedures with prolonged cardiopulmonary bypass sup-
port.3 Brachial arterial pressure may thus better guide patient 
care and clinical management than radial arterial pressure 
What We Already Know about This Topic
• Brachial arterial catheters better estimate aortic pressure than 
radial arterial catheters but are used infrequently because of 
risk of complications in a major artery without collateral flow 
are potentially serious
• The present study evaluated a large cohort of cardiac surgical 
patients to estimate the incidence of brachial artery catheter 
complications
What This Article Tells Us That Is New
• Brachial artery cannulation for hemodynamic monitoring 
during cardiac surgery rarely causes complications
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ABSTRACT
Background: Brachial arterial catheters better estimate aortic pressure than radial arterial catheters but are used infrequently 
because complications in a major artery without collateral flow are potentially serious. However, the extent to which brachial 
artery cannulation promotes complications remains unknown. The authors thus evaluated a large cohort of cardiac surgical 
patients to estimate the incidence of related serious complications.
Methods: The institutional Society of Thoracic Surgeons Adult Cardiac Surgery Database and Perioperative Health Docu-
mentation System Registry of the Cleveland Clinic were used to identify patients who had brachial artery cannulation between 
2007 and 2015. Complications within 6 months after surgery were identified by International Classification of Diseases, 
Ninth Revision diagnostic and procedural codes, Current Procedural Terminology procedure codes, and Society of Thoracic 
Surgeons variables. The authors reviewed electronic medical records to confirm that putative complications were related 
plausibly to brachial arterial catheterization. Complications were categorized as (1) vascular, (2) peripheral nerve injury, or (3) 
infection. The authors evaluated associations between brachial arterial complications and patient comorbidities and between 
complications and in-hospital mortality and duration of hospitalization.
Results: Among 21,597 qualifying patients, 777 had vascular or nerve injuries or local infections, but only 41 (incidence 
0.19% [95% CI, 0.14 to 0.26%]) were potentially consequent to brachial arterial cannulation. Vascular complications 
occurred in 33 patients (0.15% [0.10 to 0.23%]). Definitely or possibly related infection occurred in 8 (0.04% [0.02 
to 0.08%]) patients. There were no plausibly related neurologic complications. Peripheral arterial disease was associated 
with increased risk of complications. Brachial catheter complications were associated with prolonged hospitalization and 
in-hospital mortality.
Conclusions: Brachial artery cannulation for hemodynamic monitoring during cardiac surgery rarely causes complications. 
(Anesthesiology 2017; 126:1065-76)
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Downloaded from anesthesiology.pubs.asahq.org by guest on 08/13/2019
Copyright © 2017, the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Anesthesiology 2017; 126:1065-76 1066 Singh et al.
Risk of Brachial Arterial Pressure Monitoring
monitoring.6 However, brachial artery catheterization often 
is avoided because the brachial artery is the major blood sup-
ply to the forearm and hand. Thrombotic and ischemic com-
plications related to brachial artery cannulation can therefore 
critically compromise blood flow. Other potentially serious 
complications include infections and injuries to the median 
nerve. Complications consequent to brachial artery cannu-
lation may be especially common in patients with diabetes 
and peripheral vascular disease—who are especially likely to 
require cardiac surgery.
The incidence of complications related to brachial artery 
cannulation remains essentially unknown. Two recent 
reports, for example, each included fewer than 150 patients 
undergoing cardiac surgery,7,8 making them roughly two 
orders-of-magnitude smaller than necessary to accurately 
characterize the incidence of complications, much less 
potential associations between comorbidities and cannula-
tion-related complications.
We therefore evaluated vascular complications, nerve 
injury, and infections plausibly related to brachial arterial 
cannulation in patients undergoing cardiac surgery. Second, 
we examined whether patients with preexisting peripheral 
vascular disease, diabetes mellitus, carotid artery disease, 
coronary artery disease, or chronic kidney disease were at 
increased risk for complications from brachial arterial can-
nulation. Finally, we assessed the association between com-
plications from brachial arterial cannulation and length of 
hospitalization and risk of in-hospital mortality.
Materials and Methods
With Cleveland Clinic Institutional review board (Cleveland 
Clinic, Cleveland, Ohio) approval and waiver of informed 
consent, we reviewed the electronic records of patients who 
underwent cardiac surgery between January 1, 2007, and 
March 31, 2015. Using our institutional Society of Tho-
racic Surgeons (STS) database and the Perioperative Health 
Documentation System (PHDS) registry of the Cleveland 
Clinic, we identified adults who had brachial arterial cath-
eters inserted intraoperatively for hemodynamic monitoring 
during cardiac surgery. Patients who had previous surgery 
on the brachial artery or known brachial artery disease were 
excluded.
Cannulation of the left brachial artery for intraarte-
rial pressure monitoring is considered standard of care for 
patients who present for cardiac surgery at the Cleveland 
Clinic. Arterial puncture is performed with a 20-gauge intra-
venous catheter; the Seldinger technique (catheter-over-the-
wire) is then used to place a 5-inch, 20-gauge catheter for 
continuous arterial pressure monitoring.
Both registries were used to identify patients with poten-
tial brachial arterial catheter complications by detecting all 
documented vascular or nerve injury, loss of function, or 
infection within 6 months after the cardiac surgery. The 
International Classification of Diseases, Ninth Revision 
diagnostic and procedural codes and Current Procedural 
Terminology procedure codes that were used to identify 
potential brachial arterial catheter complications from the 
PHDS are listed in appendix 1. Potential complications 
related to brachial arterial cannulation also were identified 
by a search of the institutional STS database for noncardiac 
reoperations, limb ischemia, postoperative anticoagulation, 
postoperative infections involving an arm, septicemia, and 
neuroparalysis.
Among patients with potential brachial arterial complica-
tions, electronic medical records were reviewed individually 
to characterize complications as definitely related, possibly 
related, or unrelated to brachial arterial line cannulation. 
Initial chart reviews were performed by one of three anes-
thesia residents (A.S., B.B., B.J.W.). All definitely and pos-
sibly related complications were cross-validated by a second 
anesthesiology resident to confirm that the complication 
appeared related. All complications and any disagreements 
were adjudicated by an experienced attending cardiothoracic 
anesthesiologist (A.E.D.).
Complications were considered definitely or possibly 
related to brachial artery cannulation when (1) the com-
plication occurred at the same site and after insertion of 
the brachial arterial catheter; (2) the daily intensive care 
unit (ICU) progress note, cardiac surgery progress note, 
vascular medicine/surgery consult note, neurology con-
sult note, operative reports, or infectious disease consult 
notes stated that the complication was consequent to the 
brachial arterial line; and (3) the brachial arterial catheter 
was removed when the complication was identified. Once 
complications were deemed definitely or possibly related 
to brachial arterial cannulation, they were categorized as 
a vascular (brachial arterial injury, upper extremity isch-
emia, compartment syndrome), neurologic (median 
nerve injury, paresthesia), or infectious (local or systemic 
infection).
Brachial arterial injuries were further categorized as 
thrombotic, embolic, dissection, stricture, aneurysm, or 
other arterial injury. If compartment syndrome was iden-
tified, the site was recorded as upper arm, forearm, wrist, 
or hand. We recorded whether treatments were required, 
including surgical arterial repair, thrombectomy, fasciot-
omy (upper arm, forearm, wrist, hand), anticoagulation, or 
amputation.
Infectious complications were categorized as catheter-
site infection, cellulitis, bloodstream infection, septicemia, 
or other infection. When bloodstream infection or septice-
mia was identified, we categorized the events as definitely 
or possibly related to the brachial arterial catheter. Infec-
tions were considered definitely related to arterial catheter-
ization and thus the likely source of bloodstream infection 
or septicemia when one of the following criteria were met: 
(1) the organism identified from culture of the catheter tip 
matched the blood culture; (2) the ICU progress note or 
infectious disease note described a local infection at the site 
of brachial arterial cannulation; (3) the ICU daily progress 
Downloaded from anesthesiology.pubs.asahq.org by guest on 08/13/2019
Copyright © 2017, the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Anesthesiology 2017; 126:1065-76 1067 Singh et al.
PERIOPERATIVE MEDICINE
note or infectious disease consult note stated that the arte-
rial catheter was the likely source of infection; (4) other 
sources of infection were considered unlikely (for example, 
there were no other intravascular catheters). It is routine at 
our institution to remove all intravascular catheters when 
bloodstream infection or septicemia is identified, even with-
out direct evidence that a catheter was the source of infec-
tion. Infectious complications were thus labeled as possibly 
related to arterial catheterization if none of the aforemen-
tioned criteria for definitely related to brachial arterial cath-
eterization were fulfilled. We recorded whether treatments 
were required, including cannulation-site debridement and 
antibiotic therapy.
Patient demographics, comorbidities (diabetes, periph-
eral vascular disease, carotid disease, coronary artery disease, 
chronic kidney disease), type of cardiac surgery, length of 
hospital stay, and in-hospital mortality also were obtained 
from the registries.
Carotid artery disease, which is evaluated routinely by 
carotid ultrasound before cardiac surgery at our institution, 
was defined by the STS (version 2.81) data specification as 
carotid stenosis 50% or greater. Diabetes and peripheral vas-
cular disease also were defined according to the STS data 
specifications. Patients having coronary artery bypass graft-
ing were considered to have coronary artery disease. Chronic 
kidney disease was defined as estimated glomerular filtration 
rate less than 30 ml ∙ min−1 ∙ 1.73 m−2 calculated via the 
Modification of Diet in Renal Disease estimated glomeru-
lar filtration rate formula based on serum creatinine, age, 
 gender, and race.
Statistical Analysis
We summarized patient’s demographic and medical baseline 
characteristics as well as procedure related details via stan-
dard univariable summary statistics as means ± SD, median 
[first quartile, third quartile], or n (%).
The incidence of complications related to the intraop-
erative brachial arterial line insertion, our primary outcome, 
was estimated along with the 95% CI, assessed via normal 
approximation theory.9 The separate incidence of brachial 
artery vascular complications, neurologic complications, 
and infection along with 98.3% (correction for multiple 
outcomes) normality approximated CI also was reported.
Second, we reported the association between the presence 
of diabetes, peripheral vascular disease, carotid artery disease, 
chronic kidney disease and coronary artery disease, and the 
risk of complications from brachial arterial cannulation with 
multivariable logistic regression. The association between 
chronic kidney disease and risk for brachial complications 
was assessed post hoc. We considered brachial arterial com-
plications as the binary outcome and the listed conditions 
as the explanatory factors. Given the low incidence of the 
outcomes, we limited the adjustment of the reported asso-
ciations to preselected clinically relevant cofounders, which 
included patient’s age, body mass index, sex, race, American 
Society of Anesthesiologists physical status, duration of sur-
gery, surgery emergency status, number of simultaneous car-
diac procedures, duration of cardiopulmonary bypass time, 
duration of myocardial ischemia, and duration of circulatory 
arrest. The Wald test P value and the adjusted odds ratio 
along with 99% (correction for multiple comparisons) CI 
were reported for each of the baseline condition.
For the tertiary outcomes, we examined whether a 
complication related to brachial arterial cannulation was 
associated with increased length of hospitalization via mul-
tivariable linear regression model with log-transformed (to 
satisfy model normality assumption) length of hospitaliza-
tion as an outcome and status on brachial arterial compli-
cation as an exploratory factor. The Wald test P value and 
the adjusted ratio of geometric means along with 97.5% 
(correction for multiple comparisons) CI were reported. The 
association between in-hospital mortality and brachial arte-
rial cannulation complications were examined via multivari-
able logistic regression models. We reported the Wald test 
P value and the adjusted odds ratio along with 97.5% (cor-
rection for multiple comparisons) CI. Both associations were 
adjusted for history of diabetes, peripheral vascular disease, 
carotid disease, coronary artery disease, and all the baseline 
and intraoperative factors listed for the secondary analysis 
adjustment.
To adjust for multiple reported comparisons, the Bonfer-
roni correction was applied for the computed CIs and tests 
significance levels to maintain the Type I error rate at 5% 
on each primary, secondary and tertiary analysis. SAS 9.4 
statistical software (SAS Institute Inc., USA) was used for 
all analysis.
Sample Size Consideration
We planned to use all available cases and anticipated approx-
imately 3,000 eligible patients per year, total of 24,000 
patients. With 24,000 patients, we have the following pre-
cision in estimating complication incidence (precision is 
described in terms of CI width): the width of 95% CI ranges 
from 0.06 to 0.12% for incidence ranging from 0.05 to 
0.2%, respectively: CI width was estimated by use of exact 
binomial method.
Results
After review of the PHDS and STS registries, we identi-
fied 30,652 patients who had cardiac surgery between 2007 
and 2015. In 6,000 patients, documentation for an arte-
rial catheter was missing. Most of the surgeries with miss-
ing documentation occurred between 2007 and mid-2008 
(and were related to design issues in the newly implemented 
electronic anesthesia record); these patients were therefore 
excluded from analysis. A total of 21,597 patients met our 
inclusion and exclusion criteria (fig. 1), with 777 coded as 
having some form of vascular injury, nerve injury, loss of 
function, or infection within 6 months after cardiac surgery. 
Manual review of the electronic medical records confirmed 
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that 41 of 777 patients had complications that were defi-
nitely or possibly related to intraoperative brachial arterial 
catheter insertion. The corresponding incidence estimate 
(95% CI) for the combination of all three complications is 
0.19% (0.14 to 0.26%).
Demographic and baseline characteristics of the study 
population and procedural details for patients with and 
without brachial arterial complications are shown in table 1.
Complications related to brachial arterial cannulations 
occurred between the day of surgery and the 30th postopera-
tive day with the median [first, third quartile] day of compli-
cation on postoperative day 4 [2, 8]. Brachial artery vascular 
complications occurred in 33 (0.15% [0.10 to 0.23%]) 
patients, who had one or more of the following: upper 
extremity ischemia (21 patients), thrombosis (17 patients), 
embolism (2 patients), aneurysm (4 patients), compartment 
syndrome (1 patient), and other arterial injury (1 patient; 
table  2). No documented neurologic complications were 
found in any patient (estimated incidence 0.00% [0.00 to 
0.03%]). Infection occurred in 8 (0.04% [0.02 to 0.08%]) 
patients. Five of eight infections were catheter-related sepsis. 
It was not possible to determine whether the infection origi-
nated from the arterial catheter or from coexistent central-
venous catheters; thus, these complications were considered 
possibly related.
Treatment was required for 37 of the 41 patients who 
experienced complications (appendix 2). Treatment for 
vascular complications included repair of the brachial 
artery in 8 (22%) patients, thrombectomy in 18 (49%) 
patients, and fasciotomy in 1 (3%) patient. Other thera-
peutic interventions included anticoagulation in 17 (46%) 
patients, direct vascular compression in 3 (8%) patients, 
Rooke® Mitts (which promote vasodilation; Osborn Medi-
cal, USA) in 3 (8%), and thrombin injection in 1 patient 
(3%). All 8 cases of infection were treated with systemic 
antibiotic therapy.
Univariable and multivariable associations between the 
presence of diabetes, peripheral vascular disease, carotid dis-
ease, chronic kidney disease, coronary artery disease, and the 
risk of complications from brachial arterial cannulation are 
presented in table 3.
Postoperative complications and hospital events of 
patients who did and did not develop brachial arterial com-
plications are presented in table 4. The incidence of cardiac 
arrest, requirement for extracorporeal membrane oxygen-
ation support, use of intraaortic balloon counterpulsation, 
kidney failure, requirement for dialysis, prolonged ventila-
tion, and multisystem organ failure was between 5 and 20 
times greater in patients who had complications related to 
brachial arterial catheterization than in those who did not. 
Tertiary results on associations between brachial arterial 
catheter complication and length of hospitalization and in-
hospital mortality using multivariate regression are shown 
in table 5. Patients with complications had median hospital 
stays of 22 days compared with 8 days for patients without 
complications. In-hospital mortality was 24% in patients 
with brachial arterial complications compared with 1.75% 
in patients without arterial complications.
Fig. 1. Flowchart of patient selection. PHDS = Perioperative Health Documentation System; STS = Society of Thoracic Surgeons.
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Table 1. Summary of Patient Demographics, Baseline, and Procedural Characteristics (N = 21,597)
Variables
Definitive or Possible Brachial 
Artery Cannulation Complication
(N = 41)











Age, yr  64 ± 16  64 ± 14
Sex (male), n (%)  17 (41)  14,317 (66)
Race, n (%) 1  373  
  White  30 (75)  19,169 (90)
  African American  6 (15)  1,232 (6)
  Others  4 (10)  782 (4)
Body mass index, kg/m2  27.6 [23.4, 31.9] 8 27.7 [24.6, 31.6]
Medical history, n (%)     
  Coronary artery disease  24 (59)  9,152 (42)
  Myocardial infarction  9 (22)  4,071 (19)
  Heart failure  17 (41)  5,361 (25)
  Hypertension  28 (68)  14,750 (68)
  Stroke or cerebral vascular accident  2 (5)  1,876 (9)
  Diabetes mellitus  15 (37)  5,447 (25)
  Carotid disease  0 (0)  202 (1)
  Peripheral arterial disease  14 (34)  2,391 (11)
  Chronic obstructive pulmonary disease  17 (41)  4,405 (20)
  Endocarditis  6 (15)  1,254 (6)
  Chronic kidney disease†  7 (17) 27 890 (4)
  Dialysis  3 (7)  342 (2)
  Atrial fibrillation/flutter 17 10 (42) 8,665 3,479 (27)
  Complete heart block/pacer 17 0 (0) 8,668 566 (4)
  Ventricular arrhythmia 17 5 (21) 8,668 958 (7)
  Smoking  22 (54)  9,881 (46)
ASA physical status, n (%)   1  
  1  0 (0)  1 (0)
  2  0 (0)  50 (0)
  3  2 (5)  3,570 (17)
  4  39 (95)  17,678 (82)
  5  0 (0)  254 (1)
  6  0 (0)  2 (0)
New York Heart Association Functional Class, n (%) 4  3,044  
  1  6 (16)  5,020 (27)
  2  13 (35)  7,602 (41)
  3  13 (35)  4,674 (25)
  4  5 (14)  1,216 (7)
Preoperative laboratory values     
  Blood urea nitrogen, mg/dl 0 18 [14, 27] 27 18 [15, 23]
  Bilirubin, mg/dl 1 0.5 [0.4, 0.6] 213 0.6 [0.4, 0.8]
  Creatinine, mg/dl  1.0 [0.9, 1.2] 27 1.0 [0.8, 1.2]
  Hematocrit, %  37 [31, 39] 4 39 [34, 42]
  HDL cholesterol, mg/dl 15 44 [37, 51] 4,633 46 [37, 58]
  LDL cholesterol, mg/dl 15 81 [62, 104] 4,710 88 [67, 114]
  Triglycerides, mg/dl 15 101 [78, 114] 4,632 101 [73, 144]
Surgical procedure, n (%)     
  Coronary artery bypass grafting  21 (51)  7,145 (33)
  Aortic valve replacement  16 (39)  7,947 (37)
  Aortic valve repair  2 (5)  1,068 (5)
  Mitral valve replacement  7 (17)  2,340 (11)
  Mitral valve repair  9 (22)  5,172 (24)
  Pulmonary valve repair/replacement  0 (0)  133 (2)
  Tricuspid valve replacement  0 (0)  130 (1)
(Continued)
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Discussion
In more than 21,500 patients who had brachial arterial cathe-
terization for cardiac surgery, complications were infrequent, 
occurring in less than 0.2% of patients. This low incidence 
of complications is comparable with that reported for radial, 
femoral, and brachial arterial line cannulation in cardiac 
surgical, noncardiac surgical, and critically ill patients.3,7,8,10 
None of these other reports, however, included an adequate 
number of brachial arterial catheters to accurately assess the 
incidence of catheter-related complications of the brachial 
artery.3,7,8
Hypotension is associated with acute kidney and myo-
cardial injury in (noncardiac) surgical patients,5 and accu-
rate measurement of arterial blood pressure may improve 
clinical outcomes. Radial arterial systolic pressure is higher 
than central aortic pressure because amplification occurs 
as distance from the heart increases,11 although diastolic 
and mean arterial pressures decrease only slightly (about 1 
to 4 mmHg).11–13 Furthermore, radial artery pressure may 
underestimate central aortic pressure during and imme-
diately after cardiopulmonary bypass3,6,14 due in part to 
arterial spasm or thermoregulatory vasomotion.14–17 If 
radial arterial pressure is inaccurate, patient care may be 
compromised by promoting administration of vasopres-
sor or inotropic drugs, which may themselves worsen 
outcomes.18 In patients having cardiac surgery, brachial 
arterial pressure measurements better estimate mean and 
systolic central aortic pressures than radial arterial pres-
sures,3,19 and those who require hypothermic circulatory 
arrest are at especially high risk for developing large and 
prolonged radial-to-aorta pressure gradients.20 Use of 
the brachial artery for intraarterial pressure monitoring 
may thus provide a more accurate tool for hemodynamic 
monitoring.
The brachial artery is the main blood supply to the fore-
arm and hand. Before the brachial artery bifurcates into 
the radial and ulnar arteries, several branches, including 
the deep brachial, humeral nutrient, superior and inferior 
  Tricuspid valve repair  7 (17)  2,153 (10)
  Maze procedure  5 (12)  2,680 (12)
  Any aortic root, ascending aortic, or aortic arch 
replacement procedure
 12 (29)  3,510 (16)
  Descending aorta replacement  2 (5)  393 (2)
  Congenital ASD/PFO suture closure  1 (2)  372 (2)
  Removal of atrial myxoma, cardiac tumors  0 (0)  108 (1)
  Carotid endarterectomy  0 (0)  50 (0)
  Pulmonary endarterectomy  1 (2)  88 (0)
  Any congenital heart disease procedure  1 (2)  632 (3)
  Left ventricular reconstructive procedure  1 (2)  116 (1)
  Pericardiectomy  1 (2)  142 (1)
  Septal myectomy  0 (0)  1,157 (5)
  Heart transplant  1 (2)  260 (1)
  Insertion of mechanical ventricular assist device  14 (34)  1,032 (5)
History of cardiothoracic surgical procedures, n (%)     
  First surgery  26 (64)  16,292 (76)
  First reoperative surgery  12 (29)  4,103 (19)
  Second or more reoperative surgery  3 (7)  1,161 (5)
Emergent surgery, n (%)  3 (7) 1 816 (4)
Intraoperative     
  Duration of surgery, min  494 [376, 557]  359 [298, 441]
  Cardiopulmonary bypass time, min  129 [98, 182]  95 [69, 128]
  Aortic cross-clamp time, min  87 [58, 107]  71 [50, 96]
  Circulatory arrest, n (%)  6 (15)  1,125 (5)
   Duration of circulatory arrest, min  41 ± 20  26 ± 21
Values are given as mean ± SD, median [first, third quartile], or n (%), as appropriate.
*The data that were not collected in the medical records marked as missing, which is mostly race, preoperative laboratory results, New York Heart Associa-
tion Functional Class, and preoperative EKG. †Chronic kidney disease was identified if eGFR was less than 30 ml ∙ min−1 ∙ 1.73 m−2; eGFR was calculated 
based on the MDRD equation.
ASA = American Society of Anesthesiologists; ASD = atrial septal defect; eGFR = estimated glomerular filtration rate; EKG = electrocardiogram; HDL = high-
density lipoprotein; LDL = low-density lipoprotein; MDRD = Modification of Diet in Renal Disease; PFO = patent foramen ovale. 
Table 1. (Continued).
Variables 
Definitive or Possible Brachial 
Artery Cannulation Complication
(N = 41)
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ulnar collateral artery, provide collateral blood flow to the 
elbow and upper arm. However, forearm and hand perfu-
sion via these collaterals usually is insufficient if acute occlu-
sion of the brachial artery occurs. Thus vascular compromise 
can cause ischemia to the arm and consequent catastrophic 
injury, and is an overwhelming concern of brachial arterial 
cannulation. As might be expected, nearly 80% of all the 
complications were related to vascular injury or occlusion. 
The overall incidence of vascular complications, however, 
was low at 0.15% (i.e., less than 1 per 650 catheters).
Arterial catheters were removed immediately when 
complications were detected. Patients with brachial artery 
thrombosis received either thrombectomy or open repair 
of the brachial artery and postoperative anticoagulation. 
The remaining patients with upper extremity ischemia 
improved with intravenous anticoagulation. Ultrasound-
guided compression was used to treat brachial arterial 
pseudoaneurysms.21 With one exception,7 other studies 
similarly reported that surgical and/or medical treatment 
was required for all vascular complications.3,8,10
Handlogten et al.8 reported a slightly greater rate of com-
plications compared with our results after brachial arterial 
catheterization, namely 0.35%; however, this estimate was 
based on 3 complications among 858 patients, a fragile 
result that would be altered substantially by the addition or 
subtraction of a single complication. Nuttall et al.7 similarly 
reported a complication rate of 0.75% in cardiac surgical 
patients, which was also based on a single complication in 
134 patients; however, their overall complication rate of 
0.12% in approximately 1,600 patients was comparable 
with our report.
Although vascular complications after radial arterial can-
nulation recently were reported to be approximately 0.03% 
overall, complications were higher in patients undergoing 
cardiac surgery (approximately 0.07%).7 Though our vascu-
lar complication rate in cardiac surgical patients of 0.15% 
was slightly greater,7 the 95% CIs likely overlap. A direct 
comparison of safety between radial versus brachial arterial 
lines is not possible by comparing the results of separate 
reports because of confounding by differences in patient 
populations and risk factors.7 Nonetheless, complications 
after brachial arterial cannulation may be slightly higher by 
perhaps 7 to 8 complications per 10,000 brachial catheters 
compared with radial arterial cannulation. The incidence 
Table 2. Incidence of Definitely or Possibly Related 
Complications from Brachial Arterial Cannulation: Primary 








  Brachial artery vascular 
complications
33 0.15% (0.10–0.23)
   Upper extremity ischemia 21  
   Thrombosis 17  
   Embolism 2  
   Aneurysm 4  
   Compartment syndrome, 
forearm
1  
   Other arterial injury 1  
  Infection‡ 8 0.04% (0.02–0.08)
   Catheter-site infection 2  
   Cellulitis 1  
   Bloodstream infection/
septicemia
7  
  Neurologic complications 0 0.00% (0.00–0.03)
*We reported 95% CIs for the estimate of the incidence of brachial arte-
rial complications; for the specific complications, we reported 98.3% CI, 
which is Bonferroni adjusted (0.05/3 = 0.017) for multiple outcomes. †A 
patient might have more than one of the conditions in this list. ‡Five of 
eight cases of infection were line sepsis. These were identified as compli-
cations possibly related to brachial arterial cannulation, because it was not 
possible to determine whether the arterial catheter or a coexisting central 
venous catheter was the source of infection.
Table 3. The Association of Patient Comorbidities with Brachial Arterial Complications: Secondary Results (N = 21,597)
Baseline Comorbidities
Univariate Association Multivariate Association†
OR (99% CI)* P Value*
Adjusted OR
(99% CI)* P Value*
Diabetes 1.71 (0.74–3.94) 0.10 1.17 (0.45–3.03) 0.68
Peripheral arterial disease 4.16 (1.78–9.73) <0.001 2.78 (1.11–7.01) 0.004
Carotid disease‡ N/A N/A N/A N/A
Coronary artery disease 1.91 (0.84–4.33) 0.04 1.46 (0.59–3.59) 0.28
Chronic kidney disease§ 4.78 (1.69–13.51) <0.001 2.31 (0.70–7.65) 0.07
*The significance criteria for all five secondary tests were 0.01, which is Bonferroni adjusted for multiple comparisons (0.05/5 = 0.01) and corresponds 
to 99% CIs. †The association between the baseline condition (history of diabetes, peripheral vascular disease, carotid disease, coronary artery disease, 
chronic kidney disease) and postoperative brachial artery cannulation complication outcome was adjusted for patient’s age, body mass index, sex, race, 
ASA status, duration of surgery, surgery emergency status, number of simultaneous cardiac procedures, duration of cardiopulmonary bypass time, duration 
of myocardial ischemia, and duration of circulatory arrest. ‡Carotid artery disease was identified if Doppler evaluation demonstrated ≥50% stenosis. There 
were no patients with carotid disease among 41 patients who experienced complications related to brachial artery cannulation. Therefore, we were not able 
to report the association between presence of carotid disease and risk of brachial artery cannulation complication. §Chronic kidney disease was identified 
if eGFR was less than 30 ml ∙ min–1 ∙ 1.73 m–2; eGFR was calculated based on the MDRD equation.
ASA = American Society of Anesthesiologists; eGFR = estimate glomerular filtration rate; MDRD = Modification of Diet in Renal Disease; N/A = not 
 applicable; OR = odds ratio.
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of complications, however, may be higher at institutions 
in which brachial arterial cannulation is not routinely 
performed.
Patients having cardiac surgery may be at greater risk for 
complications from brachial arterial catheterization because 
they often have underlying vascular disease and experience 
perioperative hypoperfusion and low cardiac output state. 
Use of inotropic and vasopressor therapy may further jeop-
ardize peripheral tissue perfusion. Alternatively, anticoagula-
tion during cardiopulmonary bypass, perioperative platelet 
dysfunction or coagulopathy, and hypothermia impair coag-
ulation22 and might reduce thrombotic complications. 
Therefore, the extent to which our observed incidence in car-
diac surgical patients can be extrapolated to patients having 
other types of surgery remains unknown. Although Nuttall 
et al.7 reported more complications from brachial arterial 
cannulation for cardiac than noncardiac surgery, only a small 
number of patients were included, leaving the issue essen-
tially unresolved.
Only 3 of 21,597 patients (0.01%) developed infectious 
complications definitely related to brachial arterial catheter-
ization. Five additional patients developed catheter-related 
bloodstream infections, but definitive evidence that the 
arterial catheter was the source of infection was absent. Pre-
sumably, coexisting central venous catheters were the more 
likely source of infection.23 We nonetheless conservatively 
included these five patients as possible infectious complica-
tions. Our incidence of infectious complications is less than 
Table 4. Postoperative Complications and Hospital Events in Patients with and without Brachial Arterial Cannulation Complication
Postoperative Complications
Definitive or Possible Brachial Artery 
Cannulation Complication
No Brachial Artery Cannulation 
Complication
(N = 41) (N = 21,556)
Cardiac arrest 5 (12) 390 (2)
Atrial fibrillation 17 (41) 6,081 (28)
Extracorporeal membrane oxygenation 7 (17) 214 (1)
Left ventricular assist device 1 (2) 306 (1)
Intra/postoperative intraaortic balloon counterpulsation 6 (15) 527 (2)
Stroke 4 (10) 291 (1)
Transient ischemic attack 0 (0) 32 (0)
Coma/encephalopathy 1 (2) 220 (1)
Renal failure 13 (32) 1,018 (5)
Renal failure requiring dialysis 8 (20) 469 (2)
Prolonged ventilation: >24 h postoperatively 30 (73) 3,344 (16)
Pneumonia 4 (10) 273 (1)
Septicemia or bacteremia or sepsis 11 (27) 224 (1)
Gastrointestinal complication 3 (7) 767 (4)
Multisystem organ failure 4 (10) 87 (0)
Data are shown as n (%).
Table 5. The Association between Brachial Arterial Cannulation Complications and Length of Hospital Stay and In-hospital Mortality: 
Tertiary Results
Outcomes 
Raw Data Univariate Association Multivariate Association*
Definitive or Possible 
Brachial Artery Can-
nulation Complication




(97.5% CI) P Value†
Estimate  
(97.5% CI) P Value†
 (n = 41) (n = 21,556)     
Length of hospi-
talization, d
22 [14, 30] 8 [6, 14] 2.29 (1.82–2.87)‡ <0.001 1.55 (1.28–1.89)‡ <0.001
In-hospital 
 mortality
10 (24%) 378 (1.75%) 18.07 (7.93–41.18)§ <0.001 8.19 (3.08–21.78)§ <0.001
The raw data are reported as median [first, third quartiles] or n (%), as appropriate (N = 21,597).
*Multivariate linear regression was used to assess the ratio of geometric means of length of hospitalization comparing patients with brachial artery com-
plication with those without complication along with 97.5% CI. Multivariate logistic regression was used to assess the odds ratio of in-hospital mortality 
comparing patients with brachial artery complication with those without complication. Both associations were adjusted for patient’s age, body mass index, 
sex, race, ASA status, history of diabetes, peripheral vascular disease, carotid disease, coronary artery disease, duration of surgery, surgery emergency 
status, number of simultaneous cardiac procedures, duration of cardiopulmonary bypass time, duration of myocardial ischemia, and duration of circulatory 
arrest. †The Wald test P-value was reported; significance criteria were Bonferroni corrected for multiple testing and set to 0.05/2 = 0.025. ‡The ratio of 
geometric means along with 97.5% CI was reported. §The odds ratio along with 97.5% CI was reported. 
ASA = American Society of Anesthesiologists.
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most reports, which range from 0.02 to 0.36%,7,24 depend-
ing on site of arterial cannulation and patient population. 
Patients with infectious complications were treated with 
broad-spectrum intravenous antibiotics, whereas nearly one 
half required vasopressors infusion due to septic shock.
The median nerve runs close to the brachial artery in 
the antecubital fossa and paresthesia of the median nerve 
are common during brachial arterial cannulation. We thus 
expected some nerve injuries; however, we did not observe 
any reported nerve injury plausibly related to brachial artery 
cannulation among 21,597 patients. Previous studies also 
report no nerve injuries, although none were even remotely 
powered for this rare complication.3,7,8 Injury to the median 
nerve during brachial arterial cannulation is thus exceedingly 
rare and does not cause persistent neurologic dysfunction. 
Fear of this complication should not guide selection of arte-
rial cannulation site.
Unsurprisingly, patients with peripheral arterial disease 
had increased risk of complications from brachial arterial 
cannulation, possibly related to the presence of atheroma 
formation, calcification of the peripheral arteries, luminal 
narrowing, and reduced blood flow.25 We note, however, that 
the overall incidence of complications even in these patients 
was low and that peripheral arterial disease is hardly a com-
pelling reason to avoid brachial arterial catheterization if 
otherwise indicated. However, as mentioned previously, our 
low incidence of complications in cardiac surgical patients 
cannot be directly extrapolated to patients with peripheral 
vascular disease having noncardiac surgery, because peri-
operative management, such as systemic anticoagulation 
during cardiac surgery, may reduce risk of complications. 
Interestingly, patients with diabetes mellitus, coronary artery 
disease, and chronic kidney disease, all of which are asso-
ciated with arterial compromise, were not at increased risk 
from brachial arterial cannulation. Safety of brachial arterial 
cannulation has significant future implications, especially 
in patients with kidney disease, who may later require vas-
cular access for hemodialysis. We examined risk in patients 
with carotid disease, since this finding may indicate disease 
in other major arteries. However, none of the patients with 
brachial arterial line complications had preexisting carotid 
disease, suggesting that patients with carotid artery disease 
are not at increased risk, although we could not formally 
assess the association.
Patients with arterial line complications had prolonged 
hospital stays and greater in-hospital mortality. The post-
operative course in these patients, however, was compli-
cated by a much greater incidence of severe life-threatening 
postoperative complications, including cardiac arrest, kid-
ney injury requiring dialysis, multiorgan failure, and use of 
extracorporeal membrane oxygenation for severe cardiac or 
pulmonary failure refractory to conventional management. 
It seems obvious that these serious postoperative com-
plications were not directly consequent to brachial arte-
rial cannulation. Instead, it is more likely that prolonged 
cannulation and monitoring of the brachial artery was 
required in these critically ill patients who suffered from 
a low cardiac output state, required high-dose vasopressor 
therapy or mechanical circulatory support, or had com-
promised systemic and peripheral perfusion. Thus, these 
serious postoperative complications likely predisposed 
patients to brachial arterial line complications, rather than 
the possibility that brachial arterial cannulation caused 
life-threatening complications, a prolonged hospital stay, 
or greater in-hospital mortality. Although the overall inci-
dence of complications is low, increased clinical suspicion 
for vascular complications and appropriate consideration 
for alternative arterial line sites are suggested for critically 
ill patients who require prolonged high-dose pharmaco-
logic or mechanical circulatory support.
Our observational analysis has the limitations inher-
ent to its retrospective design. As in all retrospective stud-
ies, our findings rely on accurate recording of arterial line 
catheterization, comorbidities, and postoperative compli-
cations, and thus there is the possibility of underreport-
ing of complications. We were not able to report minor 
complications due to the lack of in-hospital International 
Classification of Diseases, Ninth Revision and Current 
Procedural Terminology billing codes for less severe com-
plications. It is thus likely that we missed minor self-
limited complications, but such complications are also of 
questionable clinical importance. Unlike one investigation 
that reported minor clinically insignificant complications, 
such as “temporary arterial occlusion,”24 we considered 
only clinically important vascular complications which 
included upper extremity ischemia, arterial thrombo-
sis, pseudoaneurysm, and compartment syndrome. Our 
investigation could not compare the risk of complications 
between radial and brachial arterial lines, because radial 
arterial lines are only used at our institution when contra-
indications or difficulty with brachial arterial cannulation 
are present.
Although our secondary analysis adjusted for multi-
ple confounding variables, the possibility of unmeasured 
covariates and residual confounders cannot be excluded. 
We were unable to determine the true incidence of infec-
tion because catheter tips were not always cultured; how-
ever, we conservatively included patients who experienced 
line-related sepsis, even though the central venous catheter 
was the more likely source of infection. Arterial line docu-
mentation was missing in approximately 20% of patients, 
mostly during the new implementation of our intraopera-
tive electronic documentation record when documenta-
tion was in development. However, it seems unlikely that 
including these patients would substantively influence our 
conclusions.
In summary, brachial artery cannulation during cardiac 
surgery was associated rarely with complications. Most com-
plications, unsurprisingly, were vascular. Because brachial 
artery pressure measurements better reflect aortic pressure 
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than radial arterial catheters and complications are rare, the 
brachial artery remains a reasonable site for direct arterial 
pressure measurement.
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Appendix 1. Variables Used to Identify Possible Complications Related to Brachial Arterial Catheterization from (1) ICD-9 Diagnoses 
and Procedures Codes, (2) CPT Procedure Codes from the Cleveland Clinic PHDS Registry, and (3) Postoperative Complications from 
the Institutional STS Database
Complications Description
ICD-9 Diagnoses 
or Procedure Code 
or CPT Procedure 
Code
PHDS  
Vascular injury Aneurysm of artery of upper extremity 442.0
 Chronic total occlusion of artery of the extremities 440.4
 Arterial embolism and thrombosis of upper extremity 444.21
 Air embolism as a complication of medical care not elsewhere classified 999.1
 Nontraumatic compartment syndrome of upper extremity 729.71
 Fasciotomy of hand 82.12
 Stricture of artery 39.31
 Surgical repair/exploration of brachial artery: decompression fasciotomy with brachial artery 
exploration
24495
 Fasciotomy (possible compartment syndrome) in the antecubital fossa: decompression fasci-
otomy forearm and/or wrist
25020–25025
 Thrombectomy of brachial artery 34101
Nerve injury Carpal tunnel syndrome 354.0
 Injury to median nerve 955.1
 Other neuroplasty 04.79
 Median nerve damage (tingling numbness) in antecubital fossa: neuroplasty 64718
Loss of function Other finger(s) amputation status V49.62
 Below elbow amputation status V49.65
 Digit amputation for upper extremity: amputation finger or thumb 26951, 26952
Infection Other specified local infections of skin and subcutaneous tissue 686.8
Institutional STS database*  
Infection Arm infection: infection with type “radial artery harvest site infection” or “arm” —
 Bacteremia: Indicate whether a recognized pathogen is cultured from 1 or more blood cultures
Sepsis: sepsis is defined as evidence of serious infection accompanied by a deleterious 
systemic response. In the time period of the first 48 postoperative or postprocedural hours, 
the diagnosis of sepsis requires the presence of an SIRS resulting from a proven infection 
(such as bacteremia, fungemia, or urinary tract infection). In the time period after the first 
48 postoperative or postprocedural hours, sepsis may be diagnosed by the presence of an 
SIRS resulting from suspected or proven infection. During the first 48 h, an SIRS may result 
from the stress associated with surgery and/or cardiopulmonary bypass. Thus, the clinical 
criteria for sepsis during this time period should be more stringent. An SIRS is present when 
at least two of the following criteria are present: hypo- or hyperthermia (>38.5 or <36.0), 
tachycardia or bradycardia, tachypnea, leukocytosis or leukopenia, or thrombocytopenia.
—
Neuroparalysis Indicate whether the patient had a new postoperative permanent or transient paralysis, para-




Indicate whether the patient had bleeding, hemorrhage, and/or embolic events related to anti-
coagulant therapy postoperatively. This may include patients who experience disseminated 




Indicate whether the patient had any complication producing limb ischemia. This may include 




Indicate whether the patient returned to the operating room for other noncardiac reasons. This 
includes procedures requiring a return to the operating room such as tracheostomy or gen-
eral surgery procedures. This does not include procedures performed outside the operating 
room such as gastrointestinal laboratory for PEG tube, shunts for dialysis, etc.
—
*The description corresponds to STS Adult Cardiac Surgery Database Data Specifications, version 2.81.
CPT = Current Procedural Terminology; ICD-9 = International Classification of Diseases, Ninth Revision; PEG = polyethylene glycol; PHDS = Perioperative 
Health Documentation System; SIRS = systemic inflammatory response syndrome; STS = Society of Thoracic Surgeons.
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Appendix 2: Treatment for Brachial Arterial Complications
 
Cases, No. (%) 
(n = 41)
Any treatment for brachial arterial complication* 37 (100)
  Brachial artery injury or occlusion* 29 (78)
   Surgical repair of brachial artery 8 (22)
   Thrombectomy 18 (49)
   Fasciotomy of forearm 1 (3)
   Anticoagulation 17 (46)
   Amputation 0 (0)
   Compression 3 (8)
   Thrombin injection 1 (3)
   Rooke® mitt 3 (8)
   Other 9 (2)
  Infection 8 (12)
   Antibiotic therapy 8 (12)
 Median nerve injury 0 (0)
*A patient might have multiple treatments.
Nitrous Oxide from a Peach of a Specialist: J. Warren Worcester, M.D.
After attending lectures at the New York College of Pharmacy and then the nearby College of Physicians and Surgeons, 
Joseph Warren Worcester (1860 to 1926) earned his M.D. in 1888 from another College of Physicians and Surgeons, 
the one in Baltimore, Maryland. He returned that same year to New York to marry and live with Ella Hallock, a lifelong 
Middletown resident. According to this now peach-framed trade card from the Wood Library-Museum’s Ben Z. Swanson 
Collection, Doctor Worcester was “prepared / to administer Nitrous Oxide Gas for surgical operations / wherever 
desired.” Branding himself a “Specialist in use of nitrous oxide gas for dental and general surgery,” this physician and 
dental surgeon cited his professional “change of address” to Manhattan’s “141 West 34th Street.” Using that clue, a 
diligent historical researcher can comb city directories and newspapers and date this card to c. 1892. By that year, 
this versatile physician had successfully bred the fruit brand for which he would become nationally renowned, the “Dr. 
Worcester Peach.” (Copyright © the American Society of Anesthesiologists’ Wood Library-Museum of Anesthesiology.)
George S. Bause, M.D., M.P.H., Honorary Curator and Laureate of the History of Anesthesia, Wood Library-
Museum of Anesthesiology, Schaumburg, Illinois, and Clinical Associate Professor, Case Western Reserve 
University, Cleveland, Ohio. UJYC@aol.com.
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